Epilepsy after head injury. Residual risk after varying fit-free intervals since injury

Neuropathology of the vegetative state after head injury.

Neuropsychological rehabilitation·2005

Quality of life in patients with traumatic brain injury-basic issues, assessment and recommendations.

Restorative neurology and neuroscience·2002

The minimally conscious state: definition and diagnostic criteria.

Neurology·2002

The structural basis of moderate disability after traumatic brain damage.

Journal of neurology, neurosurgery, and psychiatry·2001

Neuropathology in vegetative and severely disabled patients after head injury.

Neurology·2001

Structured computer-based training in the interpretation of neuroradiological images.

International journal of medical informatics·2001

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Factors associated with short- and long-term maintenance of sinus rhythm after successful elective electrical cardioversion.

Frontiers in cardiovascular medicine·2026

Epicardial Adipose Tissue as a Dynamic Modulator of Coronary Artery Disease Phenotypes: Pathophysiology and Therapeutic Implications.

Clinical cardiology·2026

Enhancing cycling stability by promoting high-voltage structural reversibility in high-nickel positive electrode materials.

Nature communications·2026

Internal Buffering-Interfacial Regulation Synergy Bridges Stability and Kinetics in Microsized Silicon-Carbon Anodes.

Small (Weinheim an der Bergstrasse, Germany)·2026

Achieving Stable High-Voltage All-Solid-State Lithium Batteries: Electrolytes, Interfaces, and Advanced Characterization.

Small (Weinheim an der Bergstrasse, Germany)·2026

Ultrafast Charge, Spin, and Lattice Coupling Facilitates Spin Transport as Magnon-Polarons in Yttrium Iron Garnet.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Videos

Epilepsy after head injury. Residual risk after varying fit-free intervals since injury

Related Concept Videos

Neuropathology of the vegetative state after head injury.

Quality of life in patients with traumatic brain injury-basic issues, assessment and recommendations.

The minimally conscious state: definition and diagnostic criteria.

The structural basis of moderate disability after traumatic brain damage.

Neuropathology in vegetative and severely disabled patients after head injury.

Structured computer-based training in the interpretation of neuroradiological images.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Factors associated with short- and long-term maintenance of sinus rhythm after successful elective electrical cardioversion.

Epicardial Adipose Tissue as a Dynamic Modulator of Coronary Artery Disease Phenotypes: Pathophysiology and Therapeutic Implications.

Enhancing cycling stability by promoting high-voltage structural reversibility in high-nickel positive electrode materials.

Internal Buffering-Interfacial Regulation Synergy Bridges Stability and Kinetics in Microsized Silicon-Carbon Anodes.

Achieving Stable High-Voltage All-Solid-State Lithium Batteries: Electrolytes, Interfaces, and Advanced Characterization.

Ultrafast Charge, Spin, and Lattice Coupling Facilitates Spin Transport as Magnon-Polarons in Yttrium Iron Garnet.

Related Experiment Videos

Epilepsy after head injury. Residual risk after varying fit-free intervals since injury

Related Concept Videos

Related Articles